OVERVIEW

Dermatology Research

With a strong focus on translational research, dermatology research at TRI includes research into skin conditions, skin cancer, and topical product research. 

Skin Cancer Research

Each year in Australia, skin cancers account for around 80% of all newly diagnosed cancers. To improve diagnosis and treatment of skin cancers, a number of groups at TRI are undertaking research projects on melanoma and squamous cell carcinoma.  Read more about skin cancer projects at TRI.

In 2018, it was announced that the ACRF Australian Centre of Excellence in Melanoma Imaging and Diagnosis would be based at the TRI. This centre uses 3D avatar technology to create a whole-body image in milliseconds. Read more.

Dermatology Research Centre

Research at the Centre focusses on improving trans-dermal drug delivery, diagnosis and image analysis for skin conditions, to advanced clinical research including pharmaceutical sponsored clinical trials, establishing registries for skin conditions, surveillance of skin lesions, and identifying genes associated with increased skin cancer risk. Read more

Topical Product Research

UQ Professor Michael Roberts is leading research into skin product formulation, to help inform development of generic products and optimal performance. Read more

Towards improved diagnosis of inflammatory skin rashes

Many patients are admitted to Emergency and other hospital departments each year with moderate-to-severe inflammatory skin rashes. Although most rashes are benign, certain forms - particularly drug-induced severe skin reactions - can be life threatening if they are not rapidly diagnosed and treated.

Determining the cause of a moderate-to-severe inflammatory skin rash has an immediate impact on choosing the most appropriate treatment approach. It is often difficult to identify the cause of an inflammatory skin rash using conventional tissue microscopy, as many rashes are visually indistinguishable from one another. However, there is evidence to suggest that these rashes may have different ‘inflammatory signatures’ characterised by varying expression of different immune receptors and proteins.

Spore Grant winner Professor Peter Soyer’s project focusses on establishing a rapid, highly sensitive diagnostic method to detect these inflammatory signatures in human skin, and assess whether it can be used to determine the cause of inflammatory skin rashes.

 

Key Researchers
 
Tarl Prow
Michael Roberts
Brian Giulio Gabrielli
Helmut Schaider
Kiarash Khosrotehrani
Nicholas Andrew Saunders
Nikolas Haass
H. Peter Soyer
Rick Sturm
Show More ...
Key Aims
 
  • Overall to continue our high quality work on multiple research projects and develop clinical applications to improve the outcomes in prevention, diagnosis and treatment for people with skin conditions.
  • Correlating which genes may be associated with an increased risk of skin cancer
  • Surveillance of pre-cancerous skin lesions over time to characterise the metamorphosis into skin cancer
  • Novel biopsy techniques for pain-free diagnosis and novel skin delivery technologies for enhanced drug delivery
  • Image recognition software to detect pre-cancerous and cancerous skin lesions
  • Developing a new model for drug resistance in melanoma
DERMATOLOGY RESEARCH PROGRAMS
Click a program below to learn more
 
Acrf Australian Centre Of Excellence In Melanoma Imaging and Diagnosis
Dermatology Research Centre
Article
Bold bid to beat melanoma gets $10 million boost ACRF funding awarded to revolutionise early detection of melanoma UQ Professor H. Peter Soyer has been awarded $10 million by the Australian Cancer...Read more
Event
Genodermatoses - Where Genomics Meets Dermatology Presented by Professor Ingrid Winship MBChB, MD (Human Genetics), FRACP, FACD, FAICD. Executive Director Research, Melbourne Health Professor Adult...Read more
Article
My experience in a Clinical Trial International Clinical Trial Day is the 20th May. Our Digital Communications & Marketing Officer volunteered for the skin scan clinical trial, being held at the...Read more
Event
Is Skin a Barrier or Portal to Nanoparticle Exposure? A guest speaker: Prof Nancy Monteiro-Riviere Prof. Monteiro-Riviere is a Fellow in The Academy of Toxicological Sciences, and in the American...Read more
Automated analysis of dermoscopic imagery for recognition and detection of skin cancer Conducted by Dr Prow T (UQ DRC) and PhD Candidate Sam Hames in collaboration with Professor H. Peter Soyer (UQ...Read more
Image-guided skin microbiopsy technology development Study conducted by Dr Prow T (UQ DRC) in collaboration with Professor H. Peter Soyer (UQ DRC). The aim of this study is to develop two visually...Read more
Topical Application of Minimally Invasive, Novel Microbiopsy Device Study conducted by Dr Prow T (UQ DRC) and Lin L (UQ DRC) in collaboration with Professor H. Peter Soyer (UQ DRC). Our group has...Read more
Trans-dermal Drug Delivery using Elongated Microparticles Study conducted by Dr Tarl Prow (UQ DRC) and Dr Anthony Raphael (UQ DRC) in collaboration with Professor H. Peter Soyer (UQ DRC). Delivery of...Read more
Development of Nanoparticle Mucosal Delivery Systems for siRNA-based Cancer Therapies This study is carried out at the Dermatology Research Centre in collaboration between Principal Investigator...Read more
Actinic Keratosis Surveillance Feasibility Study This study is carried out by Professor H. Peter Soyer (UQ DCR) in collaboration with Dr Rachel Neale (QIMR), Associate Professor Stephen Gilmore (UQ...Read more

Pages